A detailed history of Bridger Management, LLC transactions in Terns Pharmaceuticals, Inc. stock. As of the latest transaction made, Bridger Management, LLC holds 142,300 shares of TERN stock, worth $833,878. This represents 0.61% of its overall portfolio holdings.

Number of Shares
142,300
Previous 246,800 42.34%
Holding current value
$833,878
Previous $1.68 Million 29.4%
% of portfolio
0.61%
Previous 0.86%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$6.49 - $10.8 $678,205 - $1.13 Million
-104,500 Reduced 42.34%
142,300 $1.19 Million
Q1 2024

May 15, 2024

BUY
$4.86 - $8.19 $1.2 Million - $2.02 Million
246,800 New
246,800 $1.62 Million

Others Institutions Holding TERN

About Terns Pharmaceuticals, Inc.


  • Ticker TERN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 37,613,800
  • Market Cap $220M
  • Description
  • Terns Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops small-molecule single-agent and combination therapy candidates for the treatment of non-alcoholic steatohepatitis (NASH) and obesity. The company develops TERN-101, a liver-distributed and non-bile acid farnesoid X receptor agonist, which is in Phase IIa clinical t...
More about TERN
Track This Portfolio

Track Bridger Management, LLC Portfolio

Follow Bridger Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bridger Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Bridger Management, LLC with notifications on news.